Summary & Overview
Hernia Procedures Except Inguinal and Femoral with CC: Inpatient Reimbursement Overview
DRG 354 covers inpatient hernia procedures other than inguinal and femoral when a Complication or Comorbidity is present; it encompasses surgeries such as incisional and ventral hernia repairs that require inpatient resources. This Diagnosis-Related Group matters for inpatient reimbursement because the presence of Complication or Comorbidity increases relative resource intensity and affects Medicare payment allocation.
DRG 354 Overview
DRG 354 covers noninguinal, nonfemoral hernia procedures in inpatient settings when a Complication or Comorbidity is present, typically including incisional, ventral, diaphragmatic, or other abdominal wall hernias requiring surgical repair. This Diagnosis-Related Group groups cases by clinical complexity to adjust Medicare payment for increased resource use when a Complication or Comorbidity is documented. Accurate coding of the principal diagnosis, secondary diagnoses, and procedure codes determines classification into this Diagnosis-Related Group and influences reimbursement. Hospitals should ensure coding reflects the clinical record to align with Centers for Medicare & Medicaid Services billing rules.
Clinical Trials
- Acute perioperative management trials: studies evaluating perioperative protocols such as enhanced recovery after surgery (ERAS) pathways, regional anesthesia approaches, and strategies to reduce intraoperative and immediate postoperative complications for patients undergoing non-inguinal, non-femoral hernia repairs with documented complications or comorbid conditions. These trials enroll adult surgical inpatients with ventral, incisional, parastomal, or other complex hernias who have CC-level comorbidities (eg, diabetes, COPD, obesity), and they measure outcomes such as complication rates, length of stay, opioid use, and readmissions. This research is relevant to surgeons, hospitalists, and payers because optimized perioperative care can lower complication-driven resource use and shorten costly inpatient stays for this higher-risk DRG group.
- Comparative effectiveness studies of repair techniques and mesh strategies: randomized or pragmatic trials comparing open versus laparoscopic/robotic approaches, variations in mesh type (eg, synthetic versus biologic where appropriate), fixation methods, or component-separation techniques in patients with complex hernias and comorbidities. These studies focus on intermediate postoperative outcomes including wound infection, hernia recurrence, reoperation rates, and need for prolonged inpatient or post-acute care, specifically in patients whose baseline health places them in the CC-category. Results inform surgical decision-making and payer coverage policies because different techniques can substantially affect index hospitalization costs, complication-driven readmissions, and long-term resource utilization.
- Post-discharge outcomes and care coordination research: cohort studies or randomized trials testing interventions such as structured discharge planning, early outpatient follow-up, home health or telemedicine surveillance, and targeted management of comorbid conditions to prevent readmission and surgical site complications in CC-level hernia patients. These investigations target patients discharged after complex hernia repair who have risk factors for post-acute complications (eg, poorly controlled diabetes, obesity, or limited social support), and they measure 30- and 90-day readmissions, wound complication rates, and total payer spending across the episode of care. For providers and payers, evidence from this research helps design cost-effective post-acute pathways that reduce readmissions and downstream costs associated with this DRG.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.